PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension

Clinical trial NCT00125918 · COMPLETED

Trial details

NCT number: NCT00125918
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2005-08-01
Primary completion: 2007-08-01
Enrollment: 406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.